glp 1 bacteria GLP-1 Medicines And Gut Bacterial Overgrowth Frontiers | GLP-1 receptor agonists
Description
According to FAIR Healths 2025 analysis of more than 51 billion commercial insurance claims, the share of adults prescribed a GLP-1 medication increased from 0.9% in 2019 to 4% in 2024
Plateaus are normal and manageable
FDA-Approved DPP-4 Inhibitors: DPP-4 inhibitors are used to treat blood sugar levels in people with diabetes
Available Across the U.S
10.1016/j.molmed.2024.10.010 [DOI] [PubMed] [Google Scholar] Reich N., Hlscher C
doi: 10.1111/all.14879 [DOI] [PMC free article] [PubMed] [Google Scholar] 101
